. Increased glyceraldehyde 3-phosphate dehydrogenase levels in the brain of patients with Down's syndrome. Neurosci Lett. 1999 Jan 29;260(2):141-5. PubMed.

Recommends

Please login to recommend the paper.

Comments

  1. This is particularly interesting since G3PD is used as a loading control in many studies.

Make a Comment

To make a comment you must login or register.